Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells-Reference-Cited by-同舟云学术

Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells

Published:2006-12-26 Issue:1 Volume:104 Page:252-257
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Akazawa T.,Ebihara T.,Okuno M.,Okuda Y.,Shingai M.,Tsujimura K.,Takahashi T.,Ikawa M.,Okabe M.,Inoue N.,Okamoto-Tanaka M.,Ishizaki H.,Miyoshi J.,Matsumoto M.,Seya T.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference41 articles.

1. Cancer immunotherapy: moving beyond current vaccines

2. TAP off - tumors on

3. Innate Immunity: The Virtues of a Nonclonal System of Recognition

4. Adjuvant-Mediated Tumor Regression and Tumor-Specific Cytotoxic Response Are Impaired in MyD88-Deficient Mice

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of Ridostin Pro and Poly(I:C) as adjuvants that enhance the immunogenicity of an antitumor vaccine;Siberian journal of oncology;2024-07-04

2. HPK1 Dysregulation‐Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression;Advanced Science;2024-06-03

3. TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways;2024-04-08

4. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

5. The Functional Mechanisms of Toll-Like Receptor 3 and Its Implications in Digestive System Tumors;Frontiers in Bioscience-Landmark;2023-11-24